MHRA

MHRA warns of increased risk of adverse neurological and cardiac effects in elderly patients on haloperidol.

Dapagliflozin no longer indicated for type 1 diabetes for commercial reasons.

MHRA issues recall as a precautionary measure after excessive levels of AZBT detected.

Latest data shows 30% reduction in hospitalisation in death and not 50% as previously.

Medicines watchdog issues a class 3 recall for a batch of methadone tablets.

The packaging and information leaflet in some batches has a dosage error.

Balkeet Singh Khaira supplied controlled drugs worth more than £1m on the black market.

Molnupiravir reduces risk of hospitalisation or death for at-risk adults with mild to moderate Covid-19 by 50 per cent.

DHSS press release leads to media reports that UK could be the first country in the world to prescribe medicinally licensed e-cigarettes

Class 3 recall issued due to faulty containers in some batches.

Pfizer is recalling all in-date batches of Champix as a precautionary measure.

NHS lung cancer patients will be the first in Europe to be offered sotorasib.

Ronapreve may prevent infections and help reduce hospital admissions.

The decision will make it easier for patients to access the painkiller, says the regulator.

Framework to cover new types of medicines that are manufactured and supplied at the point of care.

Batches recalled as a precautionary measure due to contamination.

UK medicines watchdog the MHRA has announced that the first progesterone pills are to be available from pharmacies without a prescription.

Product information updated for Pfizer/BioNTech and Moderna vaccines - insufficient evidence to justify new warning for AZ vaccine.

MHRA is urgently recalling packs of Co-codamol effervescent tablets amid concerns they may contain too much or too little of the active ingredients.  

Some 113,000 websites operating illegally in the UK were removed or had their URLs blocked as part of Operation Pangea.